Point-of-care tests offer more flexibility for facilities, but implementation may pose problems, experts warn … AMDA releases new guidance for managing COVID-19 in skilled nursing facilities … FDA to consider Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis … Skin changes may be first sign of the coronavirus
